Breast cancer
Conditions
Interventions
Experimental group:biomimetic mucosa-ipratropium
Control group:Medical radioprotective agent (aokepen)
Sponsors
Binzhou Medical University Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Pathological diagnosis was breast carcinoma in situ and invasive breast cancer; 2. The preoperative clinical stage is Tis? 4N1? 3M0 (Ia IIIc) stage, breast cancer patients who received breast conserving surgery+postoperative radiotherapy or modified radical surgery+postoperative chest wall and regional lymph node radiotherapy; 4. The scar of the surgical incision was completely healed; 5. KPS score = 80; 6. No other malignant tumor and serious medical disease (especially radiation field skin disease and systemic lupus erythematosus); 7. Sign the written informed consent; 8. Age 18-60 years; 9. The patient has no serious endocrine and metabolic diseases; 10. Subjects can read, understand, follow the research procedures and independently complete the work required by the study.
Exclusion criteria
Exclusion criteria: 1. Subjects have mental illness and severe cognitive impairment; 2. Researchers believe that giving research treatment may confuse research results or lead to uncertainty risks; 3. Patients who refuse to follow up; 4. Patients who are allergic to related drugs; 5. Patients with skin-related diseases such as local dermatitis and breakage.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Degree of skin damage; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life scale; | — |
Countries
China
Contacts
Public ContactLiu Changmin
Binzhou Medical University Hospital
Outcome results
None listed